<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04170686</url>
  </required_header>
  <id_info>
    <org_study_id>833848</org_study_id>
    <nct_id>NCT04170686</nct_id>
  </id_info>
  <brief_title>Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome</brief_title>
  <official_title>Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bold Health Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to assess if a new self-help app for IBS is an acceptable and&#xD;
      effective intervention for improving the overall quality of life in patients with Irritable&#xD;
      Bowel Syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 28, 2019</start_date>
  <completion_date type="Actual">September 28, 2020</completion_date>
  <primary_completion_date type="Actual">September 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Irritable Bowel Syndrome Quality of Life</measure>
    <time_frame>8 weeks</time_frame>
    <description>A self-report measure of health related quality of life (HRQL) in people with irritable bowel syndrome. Scores range from 0 to 100. Higher scores are a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastrointestinal Symptom Rating Scale</measure>
    <time_frame>8 weeks</time_frame>
    <description>a self-report measure of GI symptom severity. Scores range from 0 to 78. Higher scores are a worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visceral Sensitivity Index</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of anxiety specific to visceral sensations. Scores range from 0 to 75. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GI Cognitions Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of catastrophizing specific to GI symptoms. Scores range from 0 to 64. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of Food Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of fear of food. Scores range from 0 to 90. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of depressive symptoms. Scores range from 0 to 27. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Anxiety and Stress Scale - Depression Subscale</measure>
    <time_frame>8 weeks</time_frame>
    <description>Self-report measure of depressive symptoms. Scores ranges from 0 to 42. Higher scores represent worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Anxiety and Stress Scale - Stress Subscale</measure>
    <time_frame>8 weeks</time_frame>
    <description>The stress subscale measures emotional reactivity to perceived stress. Scores range from 0-42 with higher scores representing worse stress reactivity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Anxiety and Stress Scale - Anxiety Subscale</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measures affective and physical symptoms of anxiety. Scores range from 0-42 with higher scores representing worse anxiety.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Immediate Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Zemedy App for Irritable Bowel Syndrome</intervention_name>
    <description>The Zemedy App for irritable bowel syndrome is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
    <arm_group_label>Immediate Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of IBS. Own a smart phone. Speak English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under age of consent (18) Diagnosed with another GI disorder (e.g. celiac disease,&#xD;
             inflammatory bowel disease)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melissa G Hunt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104-6018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <results_first_submitted>October 26, 2020</results_first_submitted>
  <results_first_submitted_qc>December 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 24, 2020</results_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Melissa Hunt, PhD</investigator_full_name>
    <investigator_title>Associate Director of Clinical Training</investigator_title>
  </responsible_party>
  <keyword>cognitive behavioral therapy</keyword>
  <keyword>self-help</keyword>
  <keyword>irritable bowel syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/86/NCT04170686/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>146 potential participants were consented and screened. 25 individuals met exclusion criteria (severe depression) and were not randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Immediate Treatment</title>
          <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
        </group>
        <group group_id="P2">
          <title>Waitlist Control</title>
          <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Screening</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Randomization and Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Immediate Treatment</title>
          <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
        </group>
        <group group_id="B2">
          <title>Waitlist Control</title>
          <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="62"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="121"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.21" spread="10.1"/>
                    <measurement group_id="B2" value="30.71" spread="10.2"/>
                    <measurement group_id="B3" value="32" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiple Race or Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Irritable Bowel Syndrome Quality of Life</title>
          <description>Scale scores range from 0-100 with higher scores reflecting more impairment (worse outcome)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.63" spread="18.67"/>
                    <measurement group_id="B2" value="60.48" spread="18.29"/>
                    <measurement group_id="B3" value="56.97" spread="18.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gastrointestinal Symptom Rating Scale</title>
          <description>Scale scores range from 0-78 with high scores representing worse GI symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.76" spread="12.77"/>
                    <measurement group_id="B2" value="37.75" spread="12.02"/>
                    <measurement group_id="B3" value="37.42" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>GI Cognitions Questionnaire</title>
          <description>Scale measures distorted, catastrophic beliefs about the social and occupational implications of having gastrointestinal symptoms. Scale scores range from 0 to 64 with higher scores representing worse outcomes (more distorted, catastrophic beliefs about GI symptoms)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.76" spread="12.77"/>
                    <measurement group_id="B2" value="37.75" spread="12.02"/>
                    <measurement group_id="B3" value="37.24" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Visceral Sensitivity Index</title>
          <description>Scale measures anxiety about visceral (gut) sensations. Scale scores range from 0 to 75 with higher scores representing more anxiety.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.74" spread="12.29"/>
                    <measurement group_id="B2" value="53.54" spread="11.44"/>
                    <measurement group_id="B3" value="52.62" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fear of Food Questionnaire</title>
          <description>Scale measures fear of food and eating. Scale scores range from 0-90 with higher scores representing more fear and impairment.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.87" spread="19.9"/>
                    <measurement group_id="B2" value="55.46" spread="18.2"/>
                    <measurement group_id="B3" value="54.13" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Patient Health Questionnaire 9</title>
          <description>The PHQ measures the frequency of the 9 cardinal symptoms of depression. Scale score range from 0-27 with higher scores representing more severe/frequent depressive symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.32" spread="5.29"/>
                    <measurement group_id="B2" value="11.03" spread="4.66"/>
                    <measurement group_id="B3" value="9.64" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Depression Anxiety and Stress Scale - Depression Subscale</title>
          <description>The depression subscale of the Depression Anxiety and Stress Scale (DASS) ranges from 0-42 with higher scores representing worse depression.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.65" spread="9.88"/>
                    <measurement group_id="B2" value="15.59" spread="10.69"/>
                    <measurement group_id="B3" value="13.57" spread="10.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Depression Anxiety and Stress Scale - Stress Subscale</title>
          <description>The Stress subscale of DASS measures emotional reactivity to perceived stress. It ranges from 0-42 with higher scores reflecting more distress.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.84" spread="9.56"/>
                    <measurement group_id="B2" value="18.71" spread="8.97"/>
                    <measurement group_id="B3" value="18.26" spread="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Depression Anxiety and Stress Scale - Anxiety Subscale</title>
          <description>The Anxiety subscale of the DASS measures the affective and physical symptoms of anxiety. It ranges from 0-42 with higher scores representing worse anxiety.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.03" spread="7.35"/>
                    <measurement group_id="B2" value="13.19" spread="9.14"/>
                    <measurement group_id="B3" value="12.6" spread="8.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Irritable Bowel Syndrome Quality of Life</title>
        <description>A self-report measure of health related quality of life (HRQL) in people with irritable bowel syndrome. Scores range from 0 to 100. Higher scores are a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Irritable Bowel Syndrome Quality of Life</title>
          <description>A self-report measure of health related quality of life (HRQL) in people with irritable bowel syndrome. Scores range from 0 to 100. Higher scores are a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.25" spread="19.78"/>
                    <measurement group_id="O2" value="58.19" spread="18.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Gastrointestinal Symptom Rating Scale</title>
        <description>a self-report measure of GI symptom severity. Scores range from 0 to 78. Higher scores are a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Gastrointestinal Symptom Rating Scale</title>
          <description>a self-report measure of GI symptom severity. Scores range from 0 to 78. Higher scores are a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.56" spread="10.12"/>
                    <measurement group_id="O2" value="38.18" spread="10.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visceral Sensitivity Index</title>
        <description>self-report measure of anxiety specific to visceral sensations. Scores range from 0 to 75. Higher scores are a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Visceral Sensitivity Index</title>
          <description>self-report measure of anxiety specific to visceral sensations. Scores range from 0 to 75. Higher scores are a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.14" spread="16.21"/>
                    <measurement group_id="O2" value="53.57" spread="12.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GI Cognitions Questionnaire</title>
        <description>self-report measure of catastrophizing specific to GI symptoms. Scores range from 0 to 64. Higher scores are a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>GI Cognitions Questionnaire</title>
          <description>self-report measure of catastrophizing specific to GI symptoms. Scores range from 0 to 64. Higher scores are a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.44" spread="13.72"/>
                    <measurement group_id="O2" value="40.84" spread="11.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fear of Food Questionnaire</title>
        <description>self-report measure of fear of food. Scores range from 0 to 90. Higher scores are a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Fear of Food Questionnaire</title>
          <description>self-report measure of fear of food. Scores range from 0 to 90. Higher scores are a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.22" spread="22.23"/>
                    <measurement group_id="O2" value="53.75" spread="18.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Health Questionnaire</title>
        <description>self-report measure of depressive symptoms. Scores range from 0 to 27. Higher scores are a worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Health Questionnaire</title>
          <description>self-report measure of depressive symptoms. Scores range from 0 to 27. Higher scores are a worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.78" spread="4.2"/>
                    <measurement group_id="O2" value="10.32" spread="4.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression Anxiety and Stress Scale - Depression Subscale</title>
        <description>Self-report measure of depressive symptoms. Scores ranges from 0 to 42. Higher scores represent worse outcome.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression Anxiety and Stress Scale - Depression Subscale</title>
          <description>Self-report measure of depressive symptoms. Scores ranges from 0 to 42. Higher scores represent worse outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.83" spread="7.88"/>
                    <measurement group_id="O2" value="15.45" spread="10.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression Anxiety and Stress Scale - Stress Subscale</title>
        <description>The stress subscale measures emotional reactivity to perceived stress. Scores range from 0-42 with higher scores representing worse stress reactivity.</description>
        <time_frame>8 weeks</time_frame>
        <population>Treatment completers and waitlist control participants at post-treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression Anxiety and Stress Scale - Stress Subscale</title>
          <description>The stress subscale measures emotional reactivity to perceived stress. Scores range from 0-42 with higher scores representing worse stress reactivity.</description>
          <population>Treatment completers and waitlist control participants at post-treatment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.72" spread="8.65"/>
                    <measurement group_id="O2" value="18.82" spread="9.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression Anxiety and Stress Scale - Anxiety Subscale</title>
        <description>Measures affective and physical symptoms of anxiety. Scores range from 0-42 with higher scores representing worse anxiety.</description>
        <time_frame>8 weeks</time_frame>
        <population>Treatment completers and waitlist control participants at post-treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Immediate Treatment</title>
            <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression Anxiety and Stress Scale - Anxiety Subscale</title>
          <description>Measures affective and physical symptoms of anxiety. Scores range from 0-42 with higher scores representing worse anxiety.</description>
          <population>Treatment completers and waitlist control participants at post-treatment</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.67" spread="6.38"/>
                    <measurement group_id="O2" value="12.05" spread="9.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Immediate Treatment</title>
          <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.&#xD;
Zemedy App for IBS: The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
        </group>
        <group group_id="E2">
          <title>Waitlist Control</title>
          <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>As is the case with most internet trials we experienced significant attrition from both arms. In the final publication, multiple imputation will be used to account for missing data and both treatment completer and intent-to-treat results will be reported.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Melissa G. Hunt</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>610-529-8055</phone>
      <email>mhunt@psych.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

